ReviewBlood advances2025

Immunoglobulin prophylaxis should be initiated after bispecific antibody therapy in multiple myeloma, regardless of IgG levels.

Rahul Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.